Rhumbline Advisers Fulgent Genetics, Inc. Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 32,927 shares of FLGT stock, worth $958,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,927
Previous 33,139
0.64%
Holding current value
$958,175
Previous $658,000
13.07%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding FLGT
# of Institutions
184Shares Held
18.1MCall Options Held
149KPut Options Held
0-
Black Rock Inc. New York, NY3.92MShares$114 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.47MShares$42.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.18MShares$34.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.14MShares$33.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.13MShares$33 Million0.01% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $881M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...